8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2015 / Randomized crossover trial
A randomized crossover trial tested the effects of consuming high-nitrate vegetables versus avoiding them for one week in 19 healthy women. The high-nitrate diet raised plasma nitrate from 24.4 to 61.0 µmol/l and nitrite from 98 to 185 nmol/l (both P < 0.05). Resting systolic blood pressure was reduced from 107 to 103 mmHg after the high-nitrate diet (P < 0.05), whereas the control diet produced no significant changes.
Ashworth A, Mitchell K, Blackwell JR, et al. Public Health Nutr, 2015. PMID 25683748
2015 / Randomized controlled trial
In a randomized controlled trial, 240 adults with metabolic syndrome were assigned to a diet focused on increased fiber consumption versus the multicomponent American Heart Association (AHA) dietary guidelines. At 12 months, mean weight change was -2.1 kg (95% CI, -2.9 to -1.3 kg) in the high-fiber group versus -2.7 kg (CI, -3.5 to -2.0 kg) in the AHA group, with a mean between-group difference of 0.6 kg (CI, -0.5 to 1.7 kg). Eight participants developed diabetes (7 in high-fiber, 1 in AHA; P = 0.066), and dropout rates were 9.9% versus 12.6% (P = 0.55). Limitations noted include unknown generalizability, lack of weight maintenance assessment after sessions ended, and lack of power for dietary equivalence.
Ma Y, Olendzki BC, Wang J, et al. Ann Intern Med, 2015. PMID 25686165
2015 / Randomized controlled trial
A double-blind trial randomized 110 patients with peripheral artery disease to foods containing 30 g of milled flaxseed (n=58) or 30 g of whole wheat (n=52) daily for 12 months. Flaxseed lowered circulating LDL cholesterol by 15% at 1 month (P=0.05), though differences between groups were not significant at 12 months (P=0.33). In participants also taking cholesterol-lowering drugs, flaxseed decreased LDL cholesterol by 8.5% at 12 months compared to a 3.0% increase with placebo (P=0.030).
Edel AL, Rodriguez-Leyva D, Maddaford TG, et al. J Nutr, 2015. PMID 25694068
2015 / Randomized crossover trial
In a randomized crossover trial, 39 healthy normotensive adults consumed three test meals with varying sodium and potassium contents on separate occasions. Adding 38 mmol potassium to a 65 mmol sodium meal significantly attenuated the postmeal decrease in flow-mediated dilatation compared with a low-potassium, high-sodium meal (P < 0.05). No significant differences were observed between meals for pulse wave velocity, central augmentation index, or blood pressure.
Blanch N, Clifton PM, Petersen KS, et al. Am J Clin Nutr, 2015. PMID 25787997
2015 / Single-arm pre-post intervention study
Thirty young females with BMI >= 20 drank 280 mL of tomato juice daily (providing 32.5 mg of lycopene) for 2 months while maintaining their normal diet and exercise. Twenty-five participants completed the trial. Supplementation significantly decreased body weight, body fat, waist circumference, BMI, cholesterol, MCP-1, and thiobarbituric reactive substances, while increasing adiponectin, triglyceride, and lycopene levels. Decreases in waist circumference, cholesterol, and MCP-1 and increases in adiponectin and lycopene occurred regardless of whether participants experienced body fat reduction.
Li YF, Chang YY, Huang HC, et al. Nutrition, 2015. PMID 25837214
2015 / Randomized crossover trial
Nine healthy young men completed four 2-week interventions (normocaloric bedrest, normocaloric ambulatory, hypocaloric bedrest, hypocaloric ambulatory) separated by 5 months to examine the effects of a 25% caloric restriction and 6° head-down bedrest. Caloric restriction showed a strong trend toward reduced basal muscle sympathetic nerve activity (22±3 vs. 14±4 burst/min, p = 0.06). Both bedrest and caloric restriction were associated with lower systolic blood pressure during lower body negative pressure (p < 0.01), but heart rate increased with bedrest and decreased with caloric restriction. Survival analysis demonstrated a significant reduction in orthostatic tolerance following caloric restriction (normocaloric finishers: 12/16; hypocaloric finishers: 6/16; p = 0.03).
Florian JP, Baisch FJ, Heer M, et al. PLoS One, 2015. PMID 25915488
2015 / Randomized crossover trial
In a randomized crossover trial, 22 acute coronary syndrome patients consumed cereal products made from organic semi-whole khorasan wheat or modern control wheat for eight weeks each. The khorasan intervention significantly lowered total cholesterol by 6.8%, LDL cholesterol by 8.1%, glucose by 8%, and insulin by 24.6% from baseline. It also reduced reactive oxygen species, tumor necrosis factor-alpha, and lipoperoxidation of circulating monocytes and lymphocytes, whereas control wheat produced no significant changes.
Whittaker A, Sofi F, Luisi ML, et al. Nutrients, 2015. PMID 25970146
2015 / Randomized crossover controlled feeding study
Ten salt-resistant and ten salt-sensitive healthy, normotensive participants completed a controlled feeding study with a run-in diet followed by a 7-day low-sodium diet (20 mmol/day) and a 7-day high-sodium diet (300 mmol/day) in random order. Brachial artery flow-mediated dilation (FMD) was lower during the high-sodium diet compared to the low-sodium diet in both groups (P < 0.001) without differing between groups (FMD: SR LS 10.6 ± 1.3%, SR HS 7.2 ± 1.5%, SS LS 12.5 ± 1.7%, SS HS 7.8 ± 1.4%). Thus, high dietary sodium impaired brachial artery FMD to a similar extent regardless of salt sensitivity.
Matthews EL, Brian MS, Ramick MG, et al. J Appl Physiol (1985), 2015. PMID 26078434
2015 / Randomized crossover trial
A randomized crossover trial evaluated adding 85 grams of almonds daily to an NCEP Step 1 diet for 6 weeks in 45 patients with coronary artery disease. Almond supplementation raised plasma α-tocopherol by 5.8% (P ≤ 0.05) and improved intakes of fiber, calcium, magnesium, and choline. However, it did not significantly alter vascular function, blood pressure, lipids, or inflammatory markers such as C-reactive protein or tumor necrosis factor-α.
Chen CY, Holbrook M, Duess MA, et al. Nutr J, 2015. PMID 26080804
2015 / Experimental animal study and pilot clinical trial
Cycles of a fasting mimicking diet extended lifespan, stimulated stem cell regeneration upon re-feeding, reduced visceral fat, decreased cancer incidence, and improved cognitive performance in mice. In a pilot clinical trial, three cycles of the fasting mimicking diet decreased risk factors and biomarkers associated with aging, diabetes, cardiovascular disease, and cancer without causing major adverse effects.
Brandhorst S, Choi IY, Wei M, et al. Cell Metab, 2015. PMID 26094889
2015 / Randomized crossover trial
Fourteen overweight postmenopausal women consumed three 2-week isocaloric diets containing high-fat cheese, high-fat meat, or high carbohydrates in a randomized crossover design. Compared to the carbohydrate diet, the cheese diet increased HDL cholesterol by 5% (P = 0.012) and the meat diet increased it by 8% (P < 0.001). Total cholesterol, LDL cholesterol, and triglycerides did not differ, whereas both cheese and meat diets increased fecal fat and bile acid excretion.
NANO counterpoint →
Thorning TK, Raziani F, Bendsen NT, et al. Am J Clin Nutr, 2015. PMID 26178720
2015 / Randomized controlled trial
In a 2-year trial, 218 nonobese adults aged 21-51 years were randomized to 25% caloric restriction or ad libitum diet. The restriction group achieved 11.7% calorie reduction and sustained 10.4% weight loss. Triiodothyronine decreased significantly more in the restricted group at 12 and 24 months (P<0.001), while weight-adjusted resting metabolic rate fell significantly more at 12 months (P=0.04) but not at 24 months. Core temperature was unchanged, and cardiometabolic risk factors decreased without harming quality of life.
Ravussin E, Redman LM, Rochon J, et al. J Gerontol A Biol Sci Med Sci, 2015. PMID 26187233
2015 / Randomized controlled trial
In an open-label randomized trial, 30 participants with metabolic syndrome were assigned to consume Lactobacillus casei Shirota three times daily (6.5 × 10^9 CFU) or standard care for 12 weeks; 28 completed the protocol. Plasma TMAO concentrations declined in both the probiotic group (4.66 ± 2.66 to 4.31 ± 2.04 μM) and controls (4.64 ± 2.75 to 4.40 ± 2.14 μM). The net changes (-0.25 ± 2.39 vs. -0.34 ± 2.23 μM) did not differ significantly between arms (p = 0.510).
Tripolt NJ, Leber B, Triebl A, et al. Atherosclerosis, 2015. PMID 26188537
2015 / Randomized crossover trial
In a randomized crossover trial, 12 adults with metabolic syndrome consumed three test meals matched for fiber or antioxidant capacity on three occasions with five hours of postprandial monitoring. Insulin was lower after the black bean meal versus the matched meals (p < 0.0001). Plasma antioxidant capacity differed over time (p = 0.002), oxidized LDL showed no difference by meal, and triglycerides and interleukin-6 rose after meals (p < 0.0001).
Reverri EJ, Randolph JM, Steinberg FM, et al. Nutrients, 2015. PMID 26225995
2015 / Randomized, open-label, parallel-arm trial with blinded endpoints
In an 86-patient randomized trial, participants completed a 4-week run-in on atorvastatin 10 mg, followed by 4 weeks on atorvastatin 40 mg, ezetimibe 10 mg, or both. In the next 4-week phase, 2.0 g of plant sterols were added to these treatments. Adding plant sterols further reduced total and LDL cholesterol by ~7.7% and 6.5%, respectively, in the atorvastatin group, and by 5.0% and 4.0% in the combination therapy group (P < .05 for all). Plant sterol supplementation produced no additional effects on markers of cholesterol absorption or synthesis.
Malina DM, Fonseca FA, Barbosa SA, et al. J Clin Lipidol, 2015. PMID 26228672
2015 / Randomized double-blind, placebo-controlled trial
A randomized, double-blind, placebo-controlled trial investigated the effect of 12 weeks of onion peel extract (OPE; 100 mg quercetin/d, n=36) versus placebo (n=36) in healthy overweight and obese individuals. Compared with baseline, the OPE group experienced a significant increase in flow-mediated dilation (from 12.5 ± 5.2 to 15.2 ± 6.1; P = 0.002), while the placebo group saw no change. Additionally, EPC counts increased significantly in the OPE group (from 44.2 ± 25.6 to 52.3 ± 18.6; P = 0.005), and the rate of participants in the lowest FMD quartile dropped from 26% to 9%.
Choi EY, Lee H, Woo JS, et al. Nutrition, 2015. PMID 26233871
2015 / Pre-post acute intervention study
Researchers evaluated the acute effects of polyphenols from an aqueous Hibiscus sabdariffa extract in healthy male volunteers by comparing transcriptomic and metabolomic data before and 3 hours after ingestion. The intervention suggested roles in mitochondrial function, energy homeostasis, cardiovascular protection, and inhibition of the renin-angiotensin system and angiotensin-converting enzyme. Serum analysis revealed a decrease in cortisol levels and a significant increase in the active vasodilator metabolite des-Arg(9)-bradykinin.
Beltrán-Debón R, Rodríguez-Gallego E, Fernández-Arroyo S, et al. Food Funct, 2015. PMID 26234931
2015 / Intervention trial (pre-post dietary challenge)
Following a 2-week eucaloric control diet, 10 nonobese men consumed a eucaloric high-fat diet (55% fat) for 5 days. Fasting plasma TMAO did not increase significantly after the diet (1.83 ± 0.21 vs 1.6 ± 0.24 μmol/L). However, postprandial plasma TMAO was significantly higher across 4 hours following a high-fat meal challenge compared with baseline: hour 1 (2.15 ± 0.28 vs 1.7 ± 0.30 μmol/L), hour 2 (2.3 ± 0.29 vs 1.8 ± 0.32 μmol/L), hour 3 (2.4 ± 0.34 vs 1.58 ± 0.19 μmol/L), and hour 4 (2.51 ± 0.33 vs 1.5 ± 0.12 μmol/L; all P < .05).
Boutagy NE, Neilson AP, Osterberg KL, et al. Nutr Res, 2015. PMID 26265295
2015 / Randomized controlled trial
In a randomized controlled trial, 150 coronary artery disease patients with low baseline HDL cholesterol were assigned to receive 10 g/d of Pakistani almonds, 10 g/d of American almonds, or no intervention for 12 weeks. At weeks 6 and 12, HDL cholesterol was 12-14% and 14-16% higher than baseline, respectively, in both almond groups. Both almond groups also had significant reductions compared to baseline in total cholesterol, triglycerides, LDL cholesterol, VLDL cholesterol, total-to-HDL and LDL-to-HDL ratios, and the atherogenic index (P < 0.05), with no differences between almond varieties. Dietary patterns, body weight, and blood pressure did not change in any group.
Jamshed H, Sultan FA, Iqbal R, et al. J Nutr, 2015. PMID 26269239
2015 / Randomized controlled trial
A 12-week randomized trial assigned 458 Bangladeshi adults to placebo, 3 g/d creatine, 400 μg/d folic acid, or creatine plus folic acid. Creatine decreased plasma guanidinoacetate by 10.6% (95% CI: 4.9, 15.9) compared to placebo and by 9.0% (95% CI: 3.4, 14.2) with folic acid versus folic acid alone. However, creatine did not significantly change plasma total homocysteine compared to controls.
Peters BA, Hall MN, Liu X, et al. J Nutr, 2015. PMID 26311810
2015 / Randomized crossover trial
In a randomized crossover trial, 28 glucose-tolerant and 27 impaired-glucose-tolerant individuals consumed 50 g carbohydrate daily from honey, sucrose, or HFCS55 for 2 weeks each, separated by 2- to 4-week washout periods. Glucose, insulin, HOMA-IR, and OGTT iAUC for glucose or insulin did not differ by sweetener treatment. Across all treatments, body weight and systolic blood pressure were unchanged, diastolic blood pressure decreased, and triglyceride concentrations increased significantly. In the impaired glucose tolerance group, high-sensitivity C-reactive protein increased in response to all sugars.
Raatz SK, Johnson LK, Picklo MJ J Nutr, 2015. PMID 26338891
2015 / Longitudinal study
A longitudinal study followed 116 adults with coronary artery disease across two three-month stages. Following an initial nutritional phase, participants were divided into a diet group with extra virgin coconut oil or diet alone. The coconut oil group showed a greater decrease in waist circumference (-2.1 ± 2.7 cm, p < 0.01) and an increase in HDL cholesterol (3.1 ± 7.4 mg/dL, p = 0.02) compared to diet alone.
NANO counterpoint →
Cardoso DA, Moreira AS, de Oliveira GM, et al. Nutr Hosp, 2015. PMID 26545671
2015 / Randomized crossover trial
A randomized, double-blind crossover feeding trial evaluated 106 healthy adults consuming four 24-day diets supplying ~3% vaccenic acid, ~3% industrial trans fatty acids, 1% cis-9,trans-11-CLA, or control. Both vaccenic acid and industrial trans fatty acids increased total cholesterol, LDL cholesterol, total-to-HDL ratio, and apolipoprotein B by 2% to 6% compared with control (p < 0.05). Conversely, cis-9,trans-11-CLA reduced triacylglycerols without altering other lipoprotein markers.
Gebauer SK, Destaillats F, Dionisi F, et al. Am J Clin Nutr, 2015. PMID 26561632
2014 / Randomized crossover trial (acute and 8-week interventions)
Researchers evaluated the acute and long-term effects of brown rice (BR) versus white rice (WR) in randomized crossover trials involving men with the metabolic syndrome. In Study 1, postprandial glucose and insulin AUC increases were lower after BR than WR (P=0.041 and P=0.045, respectively), and the decrease in FMD observed 60 min after WR (P=0.037 vs. baseline) was protected after BR. In Study 2 (n=27), 8 weeks of BR consumption decreased weight-based parameters (which returned to baseline after WR), reduced insulin resistance, and lowered total cholesterol and LDL-cholesterol levels.
Shimabukuro M, Higa M, Kinjo R, et al. Br J Nutr, 2014. PMID 23930929